- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Industry News: GE tunes into European concerns
Focusing on company technologies aimed at early stage diagnosis, GE Healthcare is advocating disease prevention and presymptomatic detection at the ECR this week. In the context of this “Early Health” model of care, GE addressed an issue Europeans were the first to be concerned about: patient radiation dose.
Focusing on company technologies aimed at early stage diagnosis, GE Healthcare is advocating disease prevention and presymptomatic detection at the ECR this week. In the context of this “Early Health” model of care, GE addressed an issue Europeans were the first to be concerned about: patient radiation dose. The company showcased its Discovery CT750 HD, optimized to cut patient radiation to a fraction of the typically applied dose. GE also focused attention on the new low-dose version of its LightSpeed VCT, the Lightspeed XTe.
GE also highlighted its flagship ultrasound scanner, the Logiq E9, released late last year and shown at RSNA 2009. Aside from bringing premium technologies to conventional applications, the E9 fuses real-time ultrasound images into those derived from CT, MR and PET/CT scans.
ECR Study Finds Mixed Results with AI on Breast Ultrasound
March 6th 2024While adjunctive use of AI led to significantly higher specificity and accuracy rates in detecting cancer on breast ultrasound exams in comparison to unassisted reading by breast radiologists, researchers noted that 12 of 13 BI-RADS 3 lesions upgraded by AI were ultimately benign, according to research presented at the European Congress of Radiology.
Can Autonomous AI Help Reduce Prostate MRI Workloads Without Affecting Quality?
March 1st 2024Based on findings from a multicenter study of over 1,600 patients, researchers at the European Congress of Radiology suggest the inclusion of autonomous artificial intelligence (AI) triage could facilitate up to a 75 percent reduction in prostate MRI reading workload.
Five Insights on Artifacts and Limitations with Contrast-Enhanced Mammography
February 29th 2024Noting that technique issues, patient positioning miscues and atypical features can all contribute to faulty interpretation with contrast-enhanced mammography (CEM), researchers at the European Congress of Radiology shared their insights on navigating artifacts and limitations with CEM.
ECR Study Examines Key Predictive Factors for Metastasis in Patients with High-Risk Prostate Cancer
February 28th 2024Sixty-five percent of patients with newly diagnosed high-risk prostate cancer may have extraprostatic extension on MRI, and PSMA PET/CT findings suggest those with Gleason scores of eight or higher have more than double the risk of metastasis, according to a new study presented at the European Congress of Radiology (ECR).
